BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chan C, Lang S, Rowbottom C, Guckenberger M, Faivre-Finn C; IASLC Advanced Radiation Technology Committee. Intensity-modulated radiotherapy for lung cancer: current status and future developments. J Thorac Oncol 2014;9:1598-608. [PMID: 25436795 DOI: 10.1097/JTO.0000000000000346] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 McAleese J, Tumelty K, Baluch S, Powell C, Drinkwater K. Assessment of the Implementation of Lung Cancer Consensus Statements From the Royal College of Radiologists in 2021; Progress and Barriers. Clin Oncol (R Coll Radiol) 2022:S0936-6555(22)00320-X. [PMID: 36109283 DOI: 10.1016/j.clon.2022.07.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Fornacon-Wood I, Chan C, Bayman N, Banfill K, Coote J, Garbett A, Harris M, Hudson A, Kennedy J, Pemberton L, Salem A, Sheikh H, Whitehurst P, Woolf D, Price G, Faivre-Finn C. Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer. Front Oncol 2022;12:835844. [PMID: 35712515 DOI: 10.3389/fonc.2022.835844] [Reference Citation Analysis]
3 Borghetti P, Guerini AE, Sangalli C, Piperno G, Franceschini D, La Mattina S, Arcangeli S, Filippi AR. Unmet needs in the management of unresectable stage III non-small cell lung cancer: a review after the 'Radio Talk' webinars. Expert Rev Anticancer Ther 2022. [PMID: 35450510 DOI: 10.1080/14737140.2022.2069098] [Reference Citation Analysis]
4 Ding Y, Yang L, Zhou Q, Bi J, Li Y, Pi G, Wei W, Hu D, Rao Q, Li H, Zhao L, Liu A, Du D, Wang X, Zhou X, Han G, Qing K. A pilot study of function-based radiation therapy planning for lung cancer using hyperpolarized xenon-129 ventilation MRI. J Appl Clin Med Phys 2022;:e13502. [PMID: 35045204 DOI: 10.1002/acm2.13502] [Reference Citation Analysis]
5 Bao Y, Yang X, Men Y, Kang J, Sun X, Zhao M, Sun S, Yuan M, Ma Z, Hui Z. Postoperative radiotherapy improves survival of patients with ypN2 non-small cell lung cancer after neoadjuvant chemotherapy followed by surgery - A propensity score matching study of the Surveillance, Epidemiology, and End Results database. Thorac Cancer 2021. [PMID: 34907665 DOI: 10.1111/1759-7714.14273] [Reference Citation Analysis]
6 Lucia F, Rehn M, Blanc-Béguin F, Le Roux PY. Radiation Therapy Planning of Thoracic Tumors: A Review of Challenges Associated With Lung Toxicities and Potential Perspectives of Gallium-68 Lung PET/CT Imaging. Front Med (Lausanne) 2021;8:723748. [PMID: 34513884 DOI: 10.3389/fmed.2021.723748] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Alhaddad L, Pustovalova M, Blokhina T, Chuprov-Netochin R, Osipov AN, Leonov S. IR-Surviving NSCLC Cells Exhibit Different Patterns of Molecular and Cellular Reactions Relating to the Multifraction Irradiation Regimen and p53-Family Proteins Expression. Cancers (Basel) 2021;13:2669. [PMID: 34071477 DOI: 10.3390/cancers13112669] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Khalifa J, Mazieres J, Gomez-Roca C, Ayyoub M, Moyal EC. Radiotherapy in the Era of Immunotherapy With a Focus on Non-Small-Cell Lung Cancer: Time to Revisit Ancient Dogmas? Front Oncol 2021;11:662236. [PMID: 33968769 DOI: 10.3389/fonc.2021.662236] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Levy A, Botticella A, Le Péchoux C, Faivre-Finn C. Thoracic radiotherapy in small cell lung cancer-a narrative review. Transl Lung Cancer Res 2021;10:2059-70. [PMID: 34012814 DOI: 10.21037/tlcr-20-305] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Afrin KT, Ahmad S. Is IMRT or VMAT superior or inferior to 3D conformal therapy in the treatment of lung cancer? A brief literature review. J Radiother Pract. [DOI: 10.1017/s146039692100008x] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Haslett K, Bayman N, Franks K, Groom N, Harden SV, Harris C, Hanna G, Harrow S, Hatton M, McCloskey P, McDonald F, Ryder WD, Faivre-Finn C. Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study. Int J Radiat Oncol Biol Phys 2021;109:1341-8. [PMID: 33232772 DOI: 10.1016/j.ijrobp.2020.11.040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Takata T, Shiraishi K, Kumagai S, Arai N, Kobayashi T, Oba H, Okamoto T, Kotoku J. Calculating and estimating second cancer risk from breast radiotherapy using Monte Carlo code with internal body scatter for each out-of-field organ. J Appl Clin Med Phys 2020;21:62-73. [PMID: 33128332 DOI: 10.1002/acm2.13060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Bertho A, Dos Santos M, François A, Milliat F. Histoire de la prise en charge des cancers bronchopulmonaires non à petites cellules de stade précoce : de la chirurgie à la radiothérapie stéréotaxique. Radioprotection 2020;55:165-72. [DOI: 10.1051/radiopro/2020050] [Reference Citation Analysis]
14 Brown S, Banfill K, Aznar MC, Whitehurst P, Faivre Finn C. The evolving role of radiotherapy in non-small cell lung cancer. Br J Radiol 2019;92:20190524. [PMID: 31535580 DOI: 10.1259/bjr.20190524] [Cited by in Crossref: 16] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
15 Jin X, Lin B, Chen D, Li L, Han C, Zhou Y, Zheng X, Gong C, Chen M, Xie C. Safety and outcomes of volumetric modulated arc therapy in the treatment of patients with inoperable lung cancer. J Cancer 2019;10:2868-73. [PMID: 31281463 DOI: 10.7150/jca.31260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
16 Cao X, Liu M, Zhai F, Li N, Bao C, Liu Y, Chen G. Comparison of different registration methods and landmarks for image-guided radiation therapy of pulmonary tumors. BMC Med Imaging 2019;19:46. [PMID: 31151424 DOI: 10.1186/s12880-019-0343-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Doi H, Nakamatsu K, Nishimura Y. Stereotactic body radiotherapy in patients with chronic obstructive pulmonary disease and interstitial pneumonia: a review. Int J Clin Oncol 2019;24:899-909. [PMID: 30937620 DOI: 10.1007/s10147-019-01432-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Appel S, Bar J, Ben-Nun A, Perelman M, Alezra D, Urban D, Ben-Ayun M, Honig N, Ofek E, Katzman T, Onn A, Chatterji S, Dubinski S, Tsvang L, Felder S, Kraitman J, Haisraely O, Rabin Alezra T, Lieberman S, Marom EM, Golan N, Simansky D, Symon Z, Lawrence YR. Comparative effectiveness of intensity modulated radiation therapy to 3-dimensional conformal radiation in locally advanced lung cancer: pathological and clinical outcomes. Br J Radiol 2019;92:20180960. [PMID: 30864828 DOI: 10.1259/bjr.20180960] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
19 Hatton MQF, Lawless CA, Faivre-Finn C, Landau D, Lester JF, Fenwick J, Simões R, McCartney E, Boyd KA, Haswell T, Shaw A, Paul J. Accelerated, Dose escalated, Sequential Chemoradiotherapy in Non-small-cell lung cancer (ADSCaN): a protocol for a randomised phase II study. BMJ Open 2019;9:e019903. [PMID: 30700475 DOI: 10.1136/bmjopen-2017-019903] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
20 Shrimali RK, Chakraborty S, Prasath S, Arun B, Chatterjee S. Impact of modern radiotherapy techniques on survival outcomes for unselected patients with large volume non-small cell lung cancer. Br J Radiol 2019;92:20180928. [PMID: 30457882 DOI: 10.1259/bjr.20180928] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Shrimali RK, Chakraborty S, Bhattacharyya T, Mallick I, Achari RB, Prasath S, Arun B, Mahata A, Vidhya Shree M, Vishnupriya E, Chatterjee S. Development and validation of a decision support tool to select IMRT as radiotherapy treatment planning modality for patients with locoregionally advanced non-small cell lung cancers (NSCLC). Br J Radiol 2019;92:20180431. [PMID: 30387364 DOI: 10.1259/bjr.20180431] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Kim SJ, Lee JW, Kang MK, Kim JC, Lee JE, Park SH, Kim MY, Lee SJ, Moon SH, Ko BS. Evaluation of the hybrid-dynamic conformal arc therapy technique for radiotherapy of lung cancer. Radiat Oncol J 2018;36:241-7. [PMID: 30309216 DOI: 10.3857/roj.2018.00171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Yegya-Raman N, Zou W, Nie K, Malhotra J, Jabbour SK. Advanced radiation techniques for locally advanced non-small cell lung cancer: intensity-modulated radiation therapy and proton therapy. J Thorac Dis 2018;10:S2474-91. [PMID: 30206493 DOI: 10.21037/jtd.2018.07.29] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
24 Salem A, Mistry H, Backen A, Hodgson C, Koh P, Dean E, Priest L, Haslett K, Trigonis I, Jackson A, Asselin MC, Dive C, Renehan A, Faivre-Finn C, Blackhall F. Cell Death, Inflammation, Tumor Burden, and Proliferation Blood Biomarkers Predict Lung Cancer Radiotherapy Response and Correlate With Tumor Volume and Proliferation Imaging. Clin Lung Cancer 2018;19:239-248.e7. [PMID: 29398577 DOI: 10.1016/j.cllc.2017.12.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
25 Verkooijen HM, Kerkmeijer LGW, Fuller CD, Huddart R, Faivre-Finn C, Verheij M, Mook S, Sahgal A, Hall E, Schultz C. R-IDEAL: A Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation Oncology. Front Oncol 2017;7:59. [PMID: 28421162 DOI: 10.3389/fonc.2017.00059] [Cited by in Crossref: 41] [Cited by in F6Publishing: 58] [Article Influence: 8.2] [Reference Citation Analysis]
26 Jacobs M, Boersma L, Dekker A, Bosmans G, van Merode F, Verhaegen F, de Ruysscher D, Swart R, Kengen C, Lambin P. What is the degree of innovation routinely implemented in Dutch radiotherapy centres? A multicentre cross-sectional study. Br J Radiol 2016;89:20160601. [PMID: 27660890 DOI: 10.1259/bjr.20160601] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
27 Haslett K, Franks K, Hanna GG, Harden S, Hatton M, Harrow S, McDonald F, Ashcroft L, Falk S, Groom N, Harris C, McCloskey P, Whitehurst P, Bayman N, Faivre-Finn C. Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study. BMJ Open 2016;6:e010457. [PMID: 27084277 DOI: 10.1136/bmjopen-2015-010457] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
28 Chiang Y, Yang JC, Hsu FM, Chen YH, Shih JY, Lin ZZ, Lan KH, Cheng AL, Kuo SH. The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic Diseases. PLoS One 2015;10:e0145936. [PMID: 26720170 DOI: 10.1371/journal.pone.0145936] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
29 Bu X, Fan X, Hao D, Guo L, Wu C, Zhou C. Regression Analysis of Non-iatrogenic Factors That Determine Adherence to Radiation Therapy. Cell Biochem Biophys 2015;72:465-9. [PMID: 25572058 DOI: 10.1007/s12013-014-0488-1] [Reference Citation Analysis]